Overview

Bioavailability and Food Effects of HRS-7535 Tablets With Different Formulating Processes in Healthy Subjects

Status:
NOT_YET_RECRUITING
Trial end date:
2024-06-15
Target enrollment:
Participant gender:
Summary
This study was designed as a a single-center, randomized, open, interleaved (3-cycle, 3-sequence) trial. It is planned to enroll 18 healthy subjects.
Phase:
PHASE1
Details
Lead Sponsor:
Shandong Suncadia Medicine Co., Ltd.